ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,519,610 | -14.3% | 461,299 | -2.9% | 0.02% | -6.2% |
| Q2 2023 | $14,611,244 | +96843.0% | 475,317 | +13.6% | 0.02% | -15.8% |
| Q1 2023 | $15,072 | -7.2% | 418,306 | +1.7% | 0.02% | -13.6% |
| Q4 2022 | $16,248 | -99.9% | 411,142 | +6.4% | 0.02% | -4.3% |
| Q3 2022 | $15,520,000 | +7.1% | 386,253 | +12.0% | 0.02% | +9.5% |
| Q2 2022 | $14,494,000 | +34.0% | 344,778 | +24.2% | 0.02% | +50.0% |
| Q1 2022 | $10,816,000 | -4.0% | 277,607 | -1.8% | 0.01% | 0.0% |
| Q4 2021 | $11,264,000 | +14.4% | 282,663 | +3.7% | 0.01% | +7.7% |
| Q3 2021 | $9,848,000 | -16.9% | 272,502 | -5.8% | 0.01% | -18.8% |
| Q2 2021 | $11,857,000 | -8.4% | 289,256 | -2.5% | 0.02% | -11.1% |
| Q1 2021 | $12,947,000 | +165.7% | 296,803 | +204.8% | 0.02% | +157.1% |
| Q4 2020 | $4,873,000 | +50.9% | 97,361 | +26.8% | 0.01% | +40.0% |
| Q3 2020 | $3,230,000 | – | 76,769 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |